医学教育

Clinical evaluation of CEA, CA19-9, CA72-4 and CA125 in gastric cancer patients with neoadjuvant chemotherapy

作者:Zhipeng Sun1 and Nengwei Zhang2 来源:医学论坛网 日期:2017-11-15
导读

         Abstract Background: In the clinical practice of neoadjuvant chemotherapy, response markers are very important. We aimed o investigate whether tumor markers CEA(carcino-embryonic antigen), CA19-9(carbohydrate antigen 19–9), CA72-4(carbohydrate antigen 72

Abstract
Background: In the clinical practice of Neoadjuvant chemotherapy, response markers are very important. We aimed
o investigate whether tumor markers CEA(carcino-embryonic antigen), CA19-9(carbohydrate antigen 19–9), CA72-4
(carbohydrate antigen 72–4), and CA125(carbohydrate antigen 125) can be used to evaluate the response to
neoadjuvant chemotherapy, and to evaluate the diagnosis and prognosis value of four tumor markers in the patients of Gastric cancer.
阅读全文请见:Clinical evaluation of CEA, CA19-9, CA72-4 and CA125 in gastric cancer patients with neoadjuvant chemotherapy
分享:

评论

我要跟帖
发表
回复 小鸭梨
发表

copyright©医学论坛网 版权所有,未经许可不得复制、转载或镜像 京ICP证120392号 京公网安备11010502031486号

京卫网审[2013]第0193号

互联网药品信息服务资格证书:(京)-经营性-2012-0005

//站内统计 //百度统计 //站长统计
*我要反馈: 姓    名: 邮    箱: